CHEN Hai-hong,TAN Wei-ping,YANG Hui-min,et al.Clinical Characteristics and Diagnostic Methods of Pulmonary Mucormycosis[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(01):175-180.
CHEN Hai-hong,TAN Wei-ping,YANG Hui-min,et al.Clinical Characteristics and Diagnostic Methods of Pulmonary Mucormycosis[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(01):175-180. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20221201.001.
Clinical Characteristics and Diagnostic Methods of Pulmonary Mucormycosis
To summarize the clinical features and prognosis of pulmonary mucormycosis (PM) in southern China, and to explore the diagnostic value of metagenomic next generation sequencing (mNGS) in PM.
Methods
2
The clinical manifestations, diagnosis, treatment and prognosis of patients diagnosed with PM in The First Affiliated Hospital of Sun Yat-sen University from January 1, 2019 to January 31, 2022 who had undergone mNGS detection in lung tissue or alveolar lavage fluid were collected retrospectively. A total of 14 patients with PM were included, including 4 patients with confirmed diagnosis and 10 patients with clinical diagnosis.
Results
2
All patients had underlying medical conditions, with hematological malignancies and diabetes being the most common. The most common symptoms were fever
(n
= 10), cough (
n
= 9) and shortness of breath (
n
= 9). Consolidation was the most common sign of chest CT, followed by mass, mostly with cavity. On laboratory tests, decreased CD4+T lymphocytes, elevated CD8+T lymphocytes, and decreased CD4+/CD8+ ratio, and presentation with pleural effusion indicate poor prognosis. The positive rate of mNGS diagnosis was 78.5%, which was significantly higher than that of histopathology (50%), fungus rapid fluorescence staining (61.5%) and fungal culture (23.1%) of bronchoalveolar lavage fluid.
Conclusions
2
Pulmonary mucormycosis is more likely to occur in patients with underlying diseases or who are immunocompromised. The clinical manifestations lack specificity. The low CD4/CD8 ratio and presentation of pleural effusion on CT imaging indicate poor prognosis of patients. mNGS is a rapid, convenient and sensitive method for the diagnosis of PM, which has advantages in the diagnosis of pulmonary mucormycosis.
关键词
Keywords
references
Patel A , Kaur H , Xess I , et al . A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India [J]. Clin Microbiol Infect , 2020 , 26 ( 7 ): 944 e949 - 944 e 915 .
Peng M , Meng H , Sun Y , et al . Clinical features of pulmonary mucormycosis in patients with different immune status [J]. J Thorac Dis , 2019 , 11 ( 12 ): 5042 - 5052 .
Qu J , Liu X , Lv X . Pulmonary mucormycosis as the leading clinical type of mucormycosis in Western China [J]. Front Cell Infect Microbiol , 2021 , 11 : 770551 .
Parize P , Muth E , Richaud C , et al . Untargeted next-generation sequencing-based first-line diagnosis of infection in immunocompromised adults: a multicentre, blinded, prospective study [J]. Clin Microbiol Infect , 2017 , 23 ( 8 ): 574 e571 - 574 e 576 .
Miao Q , Ma Y , Wang Q , et al . Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice [J]. Clin Infect Dis , 2018 , 67 ( suppl_2 ): S231 - S240 .
Skiada A , Lass FC , Klimko N , et al . Challenges in the diagnosis and treatment of mucormycosis [J]. Med Mycol , 2018 , 56 ( suppl_1 ): 93 - 101 .
Donnelly JP , Chen SC , Kauffman CA , et al . Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium [J]. Clin Infect Dis , 2020 , 71 ( 6 ): 1367 - 1376 .
Maureen MR , Theoklis EZ , Wendy LB , et al . Epidemiology and outcome of zygomycosis: a review of 929 reported cases .[J]. Clin Infect Dis , 2005 , 1 : 634 - 653 .
Jeong W , Keighley C , Wolfe R , et al . The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports [J]. Clin Microbiol Infect , 2019 , 25 ( 1 ): 26 - 34 .
Legouge C , Caillot D , Chretien ML , et al . The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? [J]. Clin Infect Dis , 2014 , 58 ( 5 ): 672 - 678 .
Lin E , Moua T , Limper AH . Pulmonary mucormycosis: clinical features and outcomes [J]. Infection , 2017 , 45 ( 4 ): 443 - 448 .
Mahalaxmi I , Jayaramayya K , Venkatesan D , et al . Mucormycosis: an opportunistic pathogen during COVID-19 [J]. Environ Res , 2021 , 201 : 111643 .
Camargo JF , Bhimji A , Kumar D , et al . Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosis [J]. PLoS One , 2015 , 10 ( 4 ): e0123171 .
Saule P , Trauet J , Dutriez V , et al . Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment [J]. Mech Ageing Dev , 2006 , 127 ( 3 ): 274 - 281 .
Marta CG , Lee WW , Cui DP , et al . T cell subset-specific susceptibility to aging [J]. Clin Immunol , 2008 , 127 ( 1 ): 107 - 118 .
Vanesa GR , Inés HF , María JC , et al . Immunological features beyond CD4 CD8 ratio values in older individuals .[J]. Aging (Albany NY) , 2021 May 26 : 13 ( 10 ): 13443 – 13459 .
Wang J , Wang Y , Han F , et al . Multiple diagnostic methods for mucormycosis: a retrospective case series [J]. J Clin Lab Anal , 2022 , 36 ( 8 ): e24588 .
Anna S , Ioannis P , Apiranthitou MD . Epidemiology and diagnosis of mucormycosis: an update [J]. J Fungi (Basel) , 2020 , 6 ( 4 ).
Prakash H , Ghosh AK , Rudramurthy SM , et al . A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment [J]. Med Mycol , 2019 , 57 ( 4 ): 395 - 402 .